Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review

Giuseppe Di Grazia, Arianna Dri, Angela Grieco, Claudia Martinelli, Michela Palleschi, Federica Martorana, Giacomo Barchiesi, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis, Lucia Del Mastro, Fabio Puglisi, Paolo Vigneri, Mario Giuliano

Open source

DOI
10.3390/cancers17172940
Published
2025-09-08
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers17172940,
  title = {Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review},
  author = {Giuseppe Di Grazia and Arianna Dri and Angela Grieco and Claudia Martinelli and Michela Palleschi and Federica Martorana and Giacomo Barchiesi and Grazia Arpino and Carmine De Angelis and Michelino De Laurentiis and Lucia Del Mastro and Fabio Puglisi and Paolo Vigneri and Mario Giuliano},
  year = {2025},
  journal = {Cancers},
  doi = {10.3390/cancers17172940},
  url = {https://doi.org/10.3390/cancers17172940}
}

RIS

TY  - JOUR
TI  - Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review
AU  - Giuseppe Di Grazia
AU  - Arianna Dri
AU  - Angela Grieco
AU  - Claudia Martinelli
AU  - Michela Palleschi
AU  - Federica Martorana
AU  - Giacomo Barchiesi
AU  - Grazia Arpino
AU  - Carmine De Angelis
AU  - Michelino De Laurentiis
AU  - Lucia Del Mastro
AU  - Fabio Puglisi
AU  - Paolo Vigneri
AU  - Mario Giuliano
PY  - 2025
JO  - Cancers
DO  - 10.3390/cancers17172940
UR  - https://doi.org/10.3390/cancers17172940
ER  - 

APA

Grazia, G. D., Dri, A., Grieco, A., Martinelli, C., Palleschi, M., Martorana, F., Barchiesi, G., Arpino, G., Angelis, C. D., Laurentiis, M. D., Mastro, L. D., Puglisi, F., Vigneri, P., & Giuliano, M. (2025). Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review. Cancers. https://doi.org/10.3390/cancers17172940

Source records